Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Jh, Bourhis"'
Publikováno v:
Blood. 80:3235-3241
Determining both myeloid and lymphoid chimerism after T-cell-depleted allogeneic bone marrow transplantation (BMT) could be helpful in the understanding of the biology of engraftment and could provide a rational method of assessing the ability of dif
Autor:
JH Bourhis, R.J. O'Reilly, John F. Donohue, Hugo Castro-Malaspina, J Bauman, Nancy A. Kernan, WR Gerritsen, Suresh C. Jhanwar
Publikováno v:
Blood. 80:217-224
Conflicting results have been published on whether or not myelodysplastic syndromes (MDS) affect all cell lineages. Involvement of myeloid and erythroid cell lineages has been regularly observed, but it remains controversial whether the different lym
Autor:
Jl, Harousseau, Attal M, Divine M, Noel Milpied, Marit G, Leblond V, Am, Stoppa, Jh, Bourhis, Caillot D, Boasson M
Publikováno v:
Europe PubMed Central
The optimal source of stem cells is a controversial issue in the field of autologous stem cell transplantation. A comparison of autologous bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) after first remission
Publikováno v:
Europe PubMed Central
Prophylactic systemic antibiotherapy with ceftriaxone (CRO) alone was tested in aplastic patients receiving total gut decontamination and treated in protected environment. To enter the study, the patients had to be afebrile when their polymorphonucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::292410c15ddd816911f52a74dde80600
http://europepmc.org/abstract/med/3059275
http://europepmc.org/abstract/med/3059275
Publikováno v:
Europe PubMed Central
Prophylactic systemic antibiotic therapy with ceftriaxone alone was tested in aplastic patients receiving total gut decontamination and treated in a protected environment. Only patients who were afebrile when their polymorphonuclear (PMN) count fell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::66b496c6fcd25e2e697376b743f04467
http://europepmc.org/abstract/med/2962087
http://europepmc.org/abstract/med/2962087
Publikováno v:
Europe PubMed Central
Six patients (aged 39 to 55 years) with stage III myelomas were treated with IV high dose melphalan (HDM) 140 mg/m2. They had previously received only one or two courses of conventional chemotherapy. The extrahematological tolerance of the procedure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8fa48d939619ffd753cc3694686635a7
http://europepmc.org/abstract/med/2971190
http://europepmc.org/abstract/med/2971190
Autor:
bernard bonnotte, Am, Burdiles, Chehimi J, Carayol G, Pardoux C, Py, Dietrich, Kubin M, Jy, Blay, Caignard A, Ibrahim A, Robinet E, Hayat M, Jl, Pico, Jh, Bourhis, Chouaib S
Publikováno v:
ResearcherID
Publons
Europe PubMed Central
Publons
Europe PubMed Central
Cytokines may be helpful in promoting hematopoietic reconstitution but have also an impact on the cellular interactions that contribute to GvHD and immunologic graft rejection. Because IL-12 is emerging as a central cytokine in immune response, we ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fc2d3782d5879126f04b7dfd98a92a20
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:A1996VJ41900005&KeyUID=WOS:A1996VJ41900005
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:A1996VJ41900005&KeyUID=WOS:A1996VJ41900005
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4b3ccd31a371a74fcb7dd01cf345345f
http://europepmc.org/abstract/med/2964030
http://europepmc.org/abstract/med/2964030
Autor:
Mohty R; Division of Hematology and Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA. rmohty@uabmc.edu.; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France. rmohty@uabmc.edu., Bazarbachi AH; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA., Labopin M; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.; Sorbonne University, Paris, France., Esteve J; Institute of Hematology and Oncology, Hospital Clinic Barcelona, Barcelona, Spain., Kröger N; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany., Cornelissen JJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands., Blaise D; Transplantation and Cellular Immunotherapy Program, Department of Hematology, Instititut Paoli Calmettes, MSC Lab, Aix Marseille University, Marseille, France., Socié G; Hopital St. Louis, Dept.of Hematology-BMT, Paris, France., Maury S; Hôpital Henri Mondor, Service d'Hematologie, Creteil, France., Ganser A; Hannover Medical School Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Gedde-Dahl T; Oslo University Hospital, Hematology and Institute of Clinical Medicine University of Oslo, Oslo, Norway., von dem Borne P; Dept. of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Bourhis JH; Gustave Roussy Cancer Campus BMT Service, Department of Hematology, Villejuif, France., Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Service d'Hématologie, Grenoble, France., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France., Pabst C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Nguyen S; Universite Paris IV, Hopital la Pitié-Salpêtrière, Hématologie Clinique, Paris, France., Chevallier P; CHU Nantes Dept. D'Hematologie, Nantes, France., Huynh A; Clinical Hematology Unit, Oncopôle, Toulouse, France., Bazarbachi A; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Nagler A; Tel Aviv University, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Ciceri F; Hematology & Bone Marrow Transplant, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mohty M; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.; Sorbonne University, Paris, France.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Scheid C; Department I of Medicine, University of Cologne, Cologne, Germany., Eikema DJ; EBMT Statistical Unit, Leiden, The Netherlands., van Gelder M; Maastricht University Medical Center, Maastricht, The Netherlands., Salmenniemi U; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Maertens J; University Hospital Gasthuisberg, Leuven, Belgium., Passweg J; University Hospital, Basel, Switzerland., Blaise D; Institut Paoli Calmettes, Marseille, France., Byrne JL; Nottingham University, Nottingham, United Kingdom., Kröger N; Department for Stem Cell Transplantation, University Medical Center, Hamburg, Germany., Sockel K; Universitätsklinikum Dresden, Dresden, Germany., Chevallier P; CHU Nantes, Nantes, France., Bourhis JH; Gustave Roussy Cancer Campus, Villejuif, France., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sengeloev H; Rigshospitalet, Copenhagen, Denmark., Finke J; University of Freiburg, Freiburg, Germany., Snowden JA; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway., Cornillon J; Centre Hospitalier Universitaire, Saint Etienne, France., Schanz U; University Hospital, Zurich, Switzerland., Patel A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Koster L; EBMT Data Office, Leiden, The Netherlands., de Wreede LC; Leiden University Medical Center, Leiden, The Netherlands., Hayden P; St. James's Hospital, Dublin, Ireland., Raj K; University College London Hospitals NHS Trust, London, United Kingdom., Drozd-Sokolowska J; Medical University of Warsaw, Warsaw, Poland., Gurnari C; University of Rome Tor Vergata, Rome, Italy., Onida F; Hematology-BMT Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., McLornan DP; University College London Hospitals NHS Trust, London, United Kingdom., Robin M; Hôpital St-Louis, Paris, France., Yakoub-Agha I; CHU de Lille, University of Lille, INSERM U1286, Infinite, Lille, France.
Publikováno v:
Blood [Blood] 2024 Jul 25; Vol. 144 (4), pp. 445-456.